The NMR structure of the peptidic urokinase type plasminogen activator antagonist cyclo[21,29][D-Cys21Cys29]-uPA21-30 has been solved to identify design strategies for peptidomimetics that interfere with the binding of urokinase type plasminogen activator with its receptor.
申请公布号
WO0216929(A3)
申请公布日期
2002.10.10
申请号
WO2001EP09668
申请日期
2001.08.21
申请人
WILEX AG;WILHELM, OLAF;BUERGLE, MARKUS;KESSLER, HORST;SCHMIEDEBERG, NIKO
发明人
WILHELM, OLAF;BUERGLE, MARKUS;KESSLER, HORST;SCHMIEDEBERG, NIKO
